Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Insider Selling: Director Bruce Sachs Sells Shares of Vertex Pharmaceuticals Inc (VRTX)

Published 2024-05-24, 08:41 p/m
Insider Selling: Director Bruce Sachs Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
VRTX
-

GuruFocus - On May 22, 2024, Bruce Sachs, Director at Vertex Pharmaceuticals Inc (NASDAQ:VRTX), executed a sale of 7,073 shares of the company. The transaction was conducted at a price of $448 per share, resulting in a total amount of $3,168,704. The sale was disclosed in a SEC Filing. Following this transaction, the insider now directly owns 40,000 shares of the company.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is a biotechnology firm that focuses on developing and commercializing therapies for the treatment of cystic fibrosis and other severe diseases.

Over the past year, Bruce Sachs has sold a total of 29,573 shares of Vertex Pharmaceuticals Inc and has not purchased any shares. The company's insider transaction history reveals a total of 58 insider sells and no insider buys over the past year.

Shares of Vertex Pharmaceuticals Inc were trading at $448 on the day of the transaction, giving the company a market cap of $117.92 billion. The price-earnings ratio of the company stands at 29.65, which is above the industry median of 28.01 and also higher than the company's historical median.

The stock's valuation according to the GF Value is $364.17, indicating a price-to-GF-Value ratio of 1.23. This suggests that Vertex Pharmaceuticals Inc is modestly overvalued.

The GF Value is calculated based on historical multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.

This insider sell event by Bruce Sachs may be of interest to current and potential investors, providing insight into insider confidence and stock valuation perspectives.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This content was originally published on Gurufocus.com

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.